Clinical Application of Noradrenaline Spillover Methodology: Delineation of Regional Human Sympathetic Nervous Responses
- 1 November 1993
- journal article
- review article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 73 (5) , 243-253
- https://doi.org/10.1111/j.1600-0773.1993.tb00579.x
Abstract
The proportionality which in general exists between rates of sympathetic nerve firing and the overflow of noradrenaline into the venous drainage of an organ provides the experimental justification for the use of measurements of noradrenaline in plasma as a biochemical measure of sympathetic nervous function. Static measurements of noradrenaline plasma concentration have several limitations. One is the confounding influence of noradrenaline plasma clearance on plasma concentration. Other drawbacks include the distortion arising from antecubital venous sampling (this represents but one venous drainage, that of the forearm), and the inability to detect regional differentiation of sympathetic responses. Clinical regional noradrenaline spillover measurements, performed with infusions of radiolabeled noradrenaline and sampling from centrally placed catheters, and derived from regional isotope dilution, overcome these deficiencies. The strength of the methodology is that sympathetic nervous function may be studied in the internal organs not accessible to nerve recording with microneurography. Examples of the regionalization of human sympathetic responses disclosed include the preferential activation of the cardiac sympathetic outflow with mental stress, cigarette smoking, aerobic exercise, cardiac failure, coronary insufficiency, essential hypertension and in ventricular arrhythmias, and the preferential stimulation or inhibition of the renal sympathetic nerves with low salt diets and mental stress, and with exercise training, respectively. By application of the same principles, regional release of the sympathetic cotransmitters neuropeptide Y and adrenaline can be studied in humans. Cotransmitter release, however, is detected only with some difficulty. In restricted circumstances we find evidence of regional cotransmitter release to plasma, such as the release of neuropeptide Y from the heart at the very high rates of sympathetic nerve firing occurring with aerobic exercise, and cardiac adrenaline release also with exercise and after loading of the neuronal adrenaline pool by intravenous infusion of adrenaline.Keywords
This publication has 69 references indexed in Scilit:
- Biochemical evidence of sympathetic denervation of the heart in pure autonomic failureClinical Autonomic Research, 1991
- Is adrenaline released by sympathetic nerves in man?Clinical Autonomic Research, 1991
- Pancreatic noradrenergic nerves are activated by neuroglucopenia but not by hypotension or hypoxia in the dog. Evidence for stress-specific and regionally selective activation of the sympathetic nervous system.Journal of Clinical Investigation, 1988
- Physiological aspects on catecholamine samplingLife Sciences, 1987
- Adrenaline-Induced Hypertension in RatsJournal of Cardiovascular Pharmacology, 1981
- Determination of norepinephrine apparent release rate and clearance in humansLife Sciences, 1979
- Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man.Circulation, 1979
- The Sympathetic-Nervous-System Defect in Primary Orthostatic HypotensionNew England Journal of Medicine, 1977
- Role of Parasympathetic Inhibition in the Hyperkinetic Type of Borderline HypertensionCirculation, 1971
- The Neurogenic Component in HypertensionCirculation, 1955